Literature DB >> 15981775

Nephrologists should voluntarily divulge survival data to potential dialysis patients: a questionnaire study.

Adrian Fine1, Bunny Fontaine, Maryann M Kraushar, Beverly R Rich.   

Abstract

BACKGROUND: For many dialysis patients, survival is no different than with certain cancers. Yet, it appears that most nephrologists do not give detailed information about survival prior to obtaining informed consent for chronic dialysis. There are no published data on whether patients wish to be so informed.
OBJECTIVE: To assess whether patients would want voluntary disclosure by their physician of their survival should they need dialysis, and if so, why?
METHOD: A questionnaire was completed by 100 general nephrology patients during their first visit to a nephrologist.
RESULTS: The vast majority of patients (97%) would want to be given life-expectancy information, and for the physician to do so without having to be prompted. Furthermore, the majority of patients would want as much information as possible, both good and bad.
CONCLUSIONS: Virtually all patients want, and therefore should receive from their physician, prognostic information about dialysis to facilitate informed decision-making. This is in accordance with current practice guidelines.

Entities:  

Mesh:

Year:  2005        PMID: 15981775

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  30 in total

1.  Are there alternatives to hemodialysis for the elderly patient with end-stage renal failure?

Authors:  Bjorg Thorsteinsdottir; Keith M Swetz; Molly A Feely; Paul S Mueller; Amy W Williams
Journal:  Mayo Clin Proc       Date:  2012-06       Impact factor: 7.616

Review 2.  Should there be an expanded role for palliative care in end-stage renal disease?

Authors:  Manjula Kurella Tamura; Lewis M Cohen
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-11       Impact factor: 2.894

3.  Older adults with CKD and acute kidney failure: do we know enough for critical shared decision making?

Authors:  Amy W Williams
Journal:  J Am Soc Nephrol       Date:  2013-11-21       Impact factor: 10.121

4.  Opportunities to improve end-of-life care in ESRD.

Authors:  Jane O Schell; Jean L Holley
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-07       Impact factor: 8.237

5.  Reliability and Utility of the Surprise Question in CKD Stages 4 to 5.

Authors:  Andrei D Javier; Rocio Figueroa; Edward D Siew; Huzaifah Salat; Jennifer Morse; Thomas G Stewart; Rakesh Malhotra; Manisha Jhamb; Jane O Schell; Cesar Y Cardona; Cathy A Maxwell; T Alp Ikizler; Khaled Abdel-Kader
Journal:  Am J Kidney Dis       Date:  2017-02-15       Impact factor: 8.860

Review 6.  Dialysis in the frail elderly--a current ethical problem, an impending ethical crisis.

Authors:  Bjorg Thorsteinsdottir; Keith M Swetz; Jon C Tilburt
Journal:  J Gen Intern Med       Date:  2013-05-18       Impact factor: 5.128

7.  Executive summary of the KDIGO Controversies Conference on Supportive Care in Chronic Kidney Disease: developing a roadmap to improving quality care.

Authors:  Sara N Davison; Adeera Levin; Alvin H Moss; Vivekanand Jha; Edwina A Brown; Frank Brennan; Fliss E M Murtagh; Saraladevi Naicker; Michael J Germain; Donal J O'Donoghue; Rachael L Morton; Gregorio T Obrador
Journal:  Kidney Int       Date:  2015-04-29       Impact factor: 10.612

8.  Provider Perspectives on Advance Care Planning for Patients with Kidney Disease: Whose Job Is It Anyway?

Authors:  Ann M O'Hare; Jackie Szarka; Lynne V McFarland; Janelle S Taylor; Rebecca L Sudore; Ranak Trivedi; Lynn F Reinke; Elizabeth K Vig
Journal:  Clin J Am Soc Nephrol       Date:  2016-04-15       Impact factor: 8.237

9.  End-of-life care preferences and needs: perceptions of patients with chronic kidney disease.

Authors:  Sara N Davison
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-14       Impact factor: 8.237

10.  Predicting six-month mortality for patients who are on maintenance hemodialysis.

Authors:  Lewis M Cohen; Robin Ruthazer; Alvin H Moss; Michael J Germain
Journal:  Clin J Am Soc Nephrol       Date:  2009-12-03       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.